H.R. 6092 would require the Department of Veterans Affairs (VA) to establish programs related to the research, diagnosis, and treatment of all stages of prostate cancer. Those requirements include developing a clinical pathway for treatment, evaluating best practices, creating a prostate cancer registry, and preparing reports. In total, CBO estimates that implementing the bill would cost $11 million over the 2021-2025 period. Such spending would be subject to the availability of appropriations.
